Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrathiomolybdate in Psoriasis Vulgaris
NCT00113542Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tetrathiomolybdate in Psoriasis vulgaris (PV), sponsored by University of Michigan. Primary endpoints: Psoriasis Area and Severity Index and Erythema, scaling, and thickness of target lesions. Started Jun 2004; status: completed.
02
Drugs
tetrathiomolybdate
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00113542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113542.